These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15593358)

  • 1. Eligibility, utilization, and costs in a California Medicaid lupus population.
    Nichol MB; Shi S; Knight TK; Wallace DJ; Weisman MH
    Arthritis Rheum; 2004 Dec; 51(6):996-1003. PubMed ID: 15593358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma costs and utilization in a managed care organization.
    Zeiger RS; Hay JW; Contreras R; Chen W; Quinn VP; Seal B; Schatz M
    J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
    McCombs JS; Luo M; Johnstone BM; Shi L
    Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C.
    Markowitz JS; Gutterman EM; Hodes D; Klaskala W
    J Viral Hepat; 2005 Mar; 12(2):176-85. PubMed ID: 15720533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of disease management on utilization of services by race/ethnicity: evidence from the Florida Medicaid program.
    Kominski GF; Morisky DE; Afifi AA; Kotlerman JB
    Am J Manag Care; 2008 Mar; 14(3):168-72. PubMed ID: 18333709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.
    Clarke AE; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; St Pierre Y; Joseph L; Penrod J; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Danoff DS; Ho V; Esdaile JM
    J Rheumatol; 1999 Jul; 26(7):1500-11. PubMed ID: 10405937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J; Fernandes AW; Nelson W
    Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.